NEW YORK (GenomeWeb) – BioMérieux today reported that its second quarter revenues rose approximately 3 percent year over year. The firm attributed growth to a diversified geographic footprint and comprehensive offerings.

For the three months ended June 30, BioMérieux reported revenues of €582.2 million ($677.1 million), up from €566.4 million in the prior-year period. Organic growth, at constant exchange rates and scope of consolidation, was about 8 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.